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Abstract: A growing body of evidence points towards
epigenetic mechanisms being responsible for a wide
range of biological phenomena, from the plasticity of
plant growth and development to the nutritional control
of caste determination in honeybees and the etiology of
human disease (e.g., cancer). With the (partial) elucidation
of the molecular basis of epigenetic variation and the
heritability of certain of these changes, the field of
evolutionary epigenetics is flourishing. Despite this, the
role of epigenetics in shaping host–pathogen interactions
has received comparatively little attention. Yet there is
plenty of evidence supporting the implication of epige-
netic mechanisms in the modulation of the biological
interaction between hosts and pathogens. The pheno-
typic plasticity of many key parasite life-history traits
appears to be under epigenetic control. Moreover,
pathogen-induced effects in host phenotype may have
transgenerational consequences, and the bases of these
changes and their heritability probably have an epigenetic
component. The significance of epigenetic modifications
may, however, go beyond providing a mechanistic basis
for host and pathogen plasticity. Epigenetic epidemiology
has recently emerged as a promising area for future
research on infectious diseases. In addition, the incorpo-
ration of epigenetic inheritance and epigenetic plasticity
mechanisms to evolutionary models and empirical studies
of host–pathogen interactions will provide new insights
into the evolution and coevolution of these associations.
Here, we review the evidence available for the role
epigenetics on host–pathogen interactions, and the utility
and versatility of the epigenetic technologies available
that can be cross-applied to host–pathogen studies. We
conclude with recommendations and directions for future
research on the burgeoning field of epigenetics as applied
to host–pathogen interactions.
What Is Epigenetics?
Few areas in biology attract as much current attention and yet
require as much presentation as the field of epigenetics. The term
‘‘epigenetics’’ was first used by Waddington to describe the process
through which genotypes give rise to phenotypes during develop-
ment [1]. Since then, there has been a burgeoning interest in the
field of epigenetics that has been coupled with a diversification in
the use of the term: epigenetics means different things to the
different fields of biology, and even within a given field, different
authors may use it in somewhat different contexts, generating a
great deal of confusion in the process [2]. Broadly speaking,
epigenetics refers to stimuli-triggered changes in gene expression
due to processes that arise independent of changes in the
underlying DNA sequence. Some of these processes have been
elucidated and include DNA methylation [3], histone modifica-
tions and chromatin-remodeling proteins [4], and DNA silencing
by noncoding RNAs (ncRNA) (BOX 1) [5]. This general definition
of ‘‘epigenetics’’ is, however, used in two broadly different
contexts. For some authors, the term ‘‘epigenetics’’ includes all
transient changes in gene expression that occur at the individual
cell level, as well as those that are propagated during mitosis in
multicellular organisms and remain stable at the time scale of an
individual (Figure 1). For clarity, we refer to this as epigenetic
plasticity (see [6]). A good example is the development of
morphologically different castes of bees from genetically identical
individuals through nutritionally triggered DNA methylation [7].
Yet for other authors, and most notably for evolutionary biologists,
the term epigenetics refers exclusively to epigenetic inheritance: the
stimuli-triggered variation in gene expression that is heritable
across generations. Here, the epigenetic changes are generated in
the germ line in multicellular organisms (either directly or
indirectly, see Jablonka and Raz [8]) or maintained clonally in
single-cell organisms (Figure 1) [8,9]. A classic example of
transgenerational epigenetic inheritance involves a change in
flower symmetry from bilateral to radial in Linaria vulgaris, which
relates to different levels of methylation of the gene Lcyc [10]. In
this review, we contend that both epigenetic plasticity and
epigenetic inheritance are important in shaping host–pathogen
interactions, and thus we use the term ‘‘epigenetics’’ to encompass
both of these definitions.
Epigenetics of Host–Pathogen Interactions
In recent years, a plethora of papers on the role of epigenetic
phenomena on gene expression and phenotype have brought
about enormous progress in other fields (such as cancer
epigenetics [11]) thanks in part to the significant advances of
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Box 1. The Epigenetic Code
Specific combinations of epigenetic modifications constitute what has been called the epigenetic code, determining the
functional (gene regulation, replication, repair, etc.) and structural features of each genomic region [68]. Histone
modifications: A widely studied epigenetic mark is constituted by the set of posttranslational modifications (PTMs) on
histones, which consist in the covalent addition of different chemical groups to particular residues, and that take place mostly in
the tails of histones (see figure box). The association between different histone marks or variants and distinct chromatin and
functional states (or histone code [69]) is well established. For instance, trimethylation of the histone 3 lysine 4 residue
(H3K4me3) is usually linked to active genes, while trimethylation in lysine 9 residue (H3K9me3) is characteristic of repressed
chromatin. DNA methylation: The DNA of most species is methylated and this modification takes place postreplicatively. In
eukaryotes the modified base is 5-methylcytosine (5 mC) whereas in prokaryotes is mostly N6-methyladenine (6 mA) [70]. DNA
methylation has a role in silencing gene expression and heterochromatin remodeling, among other functions [3]. DNA
methylation patterns are dynamic and have changed several times through the tree of life, exhibiting a considerable structural,
functional,and mechanistic diversity [71]. Hence, while in plants and vertebrates, DNA methylation occurs widely at CpG (C—
phosphate—G) dinucleotide sites, regions of DNA where a cytosine nucleotide occurs next to a guanine nucleotide in the linear
sequence of bases, and appear preferentially associated with transposons and silenced DNA; in invertebrates, DNA methylation
is mainly found in gene bodies, but its regulatory function is only partially understood [72]. Interestingly, DNA methylation is
not ubiquitous across the tree of life. Several species seem to have undergone loss of DNA methylation to a large degree,
including model-species such as the nematode C. elegans, the insect D. melanogaster, and the yeast S. cerevisiae. RNA-
mediated silencing: A variety of noncoding RNAs (ncRNA) have been shown to act in concert with the cell’s epigenetic
machinery, for example by establishing DNA methylation and by regulating histone modifiers [5]. Among those, the best
characterized are the so-called microRNAs (miRNA), small ncRNAs of 19 to 24 nucleotides that bind target messenger RNAs and
induce their translational repression, cleavage, or accelerated decay [73]. Yet the nature and function of this class of molecules
are poorly understood, as well as the degree to which they contribute to epigenetic phenomena.
Figure BOX 1. Types of epigenetic modifications. (A) Histones can undergo phosphorylation (Ph), methylation (Me), and acetylation (Ac), among other
chemical modifications. These modifications are involved in chromatin remodeling and transcriptional regulation. (B) DNA molecules are methylated
by the addition of a methyl group to carbon position 5 on cytosine bases, a reaction catalyzed by DNA methyltransferase enzymes, which maintains
repressed gene activity. (C) mRNA is translated into a protein product, but this process can be repressed by binding of microRNAs (miRNA), a class of
noncoding RNA (ncRNA). Figure adapted with permission from [45].
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epigenetic technologies (see Box 2 and Table S1). Conversely,
we still know comparatively little about the extent and
significance of epigenetic variation in host–pathogen interactions
(Figure 2).
Host–pathogen interactions are amongst the most plastic and
dynamic systems in nature. To cope with the selective
constraints imposed by their hosts, many pathogens have
evolved an unparalleled level of phenotypic plasticity in their
life history traits [12]. Likewise, the host phenotype is drastically
and rapidly altered by the presence of a pathogen, and in some
cases, the parasitized phenotype is inherited across host
generations (see [13] for a review). In addition, co-adaptations
between hosts and pathogens often occur over such short
evolutionary time scales as to call into question the sole role of
genetic modifications (i.e., mutation and/or recombination) as
an underlying mechanism [14]. In this sense, epigenetic
modifications may provide an accessory source of fast-acting,
reversible, and readily available phenotypic variation that can
be directly shaped by both host and pathogen selection pressures
(Figure 3) [9,14].
We describe herein recent examples of host–pathogen studies
where epigenetic processes have already been shown to play a
role and which can be broadly classified into (1) pathogen
plasticity and (2) pathogen-induced alterations of the host
(Table 1).
Pathogen Plasticity
One of the most notorious aspects of pathogens is the
morphological and developmental plasticity they exhibit, which
is intimately linked to their survival and transmission in the host.
Complex life-history transitions that occur in response to the
changing host environment require rapid and profound alterations
of their gene expression profiles. Take, for example, the malaria
parasites in the genus Plasmodium. In the vertebrate host, the
parasite has distinct hepatocytic and erythrocytic stages, and it
forms sexually differentiated gametocytes in the blood that are
taken up by the mosquito, where these gametocytes mate, then
migrate through the midgut to form oocysts and from there to the
salivary glands as sporozoites. Previous studies have revealed
distinct gene expression profiles in all of these phases (reviewed in
[15]), suggesting that developmental switches are transcriptionally
regulated. However, apicomplexan parasites such as Plasmodium
are notoriously poor in transcription factors [16]. In contrast, these
parasites contain a rich repertoire of histone variants, chromatin
and histone modifying enzymes, and RNA-mediated silencing
mechanisms [17,18]. In Toxoplasma gondii, histone acetylation has
been shown to be responsible for the switch between the
replicative and nonreplicative stages of the pathogen [19,20].
Similar mechanisms of epigenetic regulation have been charac-
terized in other protists (Table 1). Although less studied,
Figure 1. Mechanisms of epigenetic plasticity and inheritance. In single-cell organisms, epimutations induced by environmental stimuli (i.e.,
host) propagate in daughter cells by mitosis and result in transient or stable epigenetic states. In multicellular, sexually reproducing, organisms the
zygote (F1) differentiates into germinal and somatic cells. Epimutations can be originated directly in the germline and propagated by mitosis
(‘‘germline induction’’) (A), or they can arise and propagate as a consequence of interactions with the soma (‘‘somatic induction’’) (B). In the soma,
after several rounds of cell divisions, epimutations tend to accumulate during cell and tissue differentiation processes (C). Only those epimutations
generated in the germline that escape meiotic resetting during gametogenesis and oogenesis are expected to have transgenerational consequences
(i.e., epigenetic inheritance) (F2).
doi:10.1371/journal.ppat.1003007.g001
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Trypanosoma brucei is the only Apicomplexa where DNA methyl-
ation has been detected, but the significance of these epigenetic
modifications in parasite cell-cycle regulation remains unexplored
[18]. More recently, DNA methylation has been shown to be
responsible for the transition between the yeast and hyphal forms
of the polymorphic yeast Candida albicans [21].
The second striking aspect of pathogen plasticity concerns their
ability to alter the expression of genes linked to virulence processes,
which allows them to colonize, replicate, and/or disseminate
within the host. Within the Apicomplexa, Plasmodium falciparum
switches its variant surface proteins during its erythrocytic stage to
avoid the host’s immune system (antigenic variation). These
Box 2. Methods of Epigenetic Analysis
Over the last decade, numerous techniques have been
developed to analyze epigenetic marks at both genome-
wide and sequence-specific levels. Here we summarize novel
and cutting-edge methodologies that due to their versatile
and straightforward nature can be cross-applied to host–
parasite studies (refer to Table S1). A more comprehensive
list of available technologies may be found elsewhere
[11,74].
DNA methylation
As a first step in any epigenetic study, global DNA
methylation analyses allow the detection and identifica-
tion of DNA methylation (either C and/or A methylnucleo-
tides) and measure its frequency throughout the genome.
These approaches do not require previous knowledge of the
genome of reference, and most rely on a prior enzymatic/
chemical hydrolysis of DNA to obtain the 29-deoxymononu-
cleosides, followed by the subsequent separation by
chromatographic means such as High Performance Liquid
Chromatography (HPLC) [75] or High Performance Capillary
Electrophoresis (HPCE) [76], and a final detection step by UV
spectroscopy or mass spectrometry. Alternatively, the global
content of DNA methylation can also be quantified by
enzymatic approaches such as the Luminometric Methylation
Assay (LUMA) [77]. This technique is based on the digestion
of DNA by methylation-sensitive and -insensitive isoschizo-
mers (HpaII/MspI) and followed by pyrosequencing [78] to
measure the extent of endonucleases cleavage.
Once the type of DNA methylation is determined, the next
step is to study the distribution and extent of DNA
methylation. The majority of methods are based on three
strategies: DNA digestion by methylation-sensitive restriction
enzymes, DNA bisulphite conversion, and affinity enrichment
of methylated DNA using specific antibodies. The combina-
tion of these techniques with different molecular and
analytical procedures has resulted in a plethora of approach-
es for determining DNA methylation patterns both at the
specific and the genomic scales. At the scale of specific
sequences, the bisulphite sequencing has become the
gold-standard in mapping m5C sites at single base-pair
resolution [79]. Following the bisulphite DNA treatment,
cytosines in single-stranded DNA are deaminated to give
uracil. After PCR amplification and DNA sequencing using
primers that do not contain any CpG site, nonmethylated
cytosines are recognized as thymines, while methylated
cytosines remain as cytosines. This way, any cytosine that
remains in bisulphite-treated DNA must have been methyl-
ated. But in recent years there have been major advances at
the level of whole methylomes, and numerous techniques
have been developed that now allow the study of DNA
methylation at a genome-wide scale. The Amplification of
Inter-Methylated Sites (AIMS) [80] is based on the
differential enzymatic digestion of genomic DNA with
methylation-sensitive and -insensitive isoschizomers (SmaI/
XmaI) followed by the ligation of specific adapters and the
amplification by PCR of the methylated sequences. Ampli-
cons are resolved in denaturing polyacrylamide-sequencing
gels, resulting in readable fingerprints that represent the
organismal cell’s DNA methylation profile. It has been widely
applied to study DNA methylation in cancer [81], and more
recently, to the discovery of DNA methylation in a social
insect (Apis mellifera) [82]. Another straightforward approach
is Methylated DNA Immunoprecipitation (MeDIP) [83],
which is based on the isolation of methylated DNA
fragments using an antibody specific for 5-methylcytosines.
The utility of this technique depends upon the quality of the
available antibodies, which at present limits the MeDIP
analysis to 5 mC. Among the newest genome-wide technol-
ogies that can be applied to host–parasite studies, micro-
array technology provides a good resolution DNA meth-
ylation profiling, but its use is restricted to the availability of
specific probes. In addition, in nonmodel organisms, a
custom array must be designed. In recent years, fast
advances in Next Generation Sequencing (NGS) have
been successfully incorporated to analyze DNA methylation
in a cost-effective manner, particularly when combined with
enrichment techniques like the MeDIP-seq [84]. Nowadays,
complete methylomes can be obtained at single-base
resolution by sequencing bisulphite converted whole
genomes [85]. This approach requires, however, complex
bioinformatic analysis because bisulphite conversion signif-
icantly reduces the complexity of the genome by converting
Cs into Ts, thus complicating the alignment of short reads to
reference genomes. More recently, several new technologies
under development that will reach the market during 2012
appear to be able to detect different DNA modifications
directly without the bisulphite transformation. These tech-
nologies include the nanopore-based methods [86] and
single molecule real time (SMRT) DNA sequencing [87].
Modifications and variants of histones
The identification and quantification of the posttranslational
modifications (PTMs) and histone variants is an essential first
characterization step, especially in nonorganisms models.
Mass spectrometry is the gold standard in terms of
accuracy [88]. However, most epigenetic research in this field
focuses on detecting the association of individual proteins
and histones with specific genomic regions. At present, the
most powerful technique is Chromatin ImmunoPrecipi-
tation (ChIP) [89]. After cross-linking DNA-binding proteins
to DNA with formaldehyde in vivo, the chromatin is isolated
and the DNA along with its associated proteins are sheared
into small fragments. The DNA binding protein of interest is
then precipitated using specific antibodies to isolate the
complex, and as a final step, the cross-link is reverted to
release the DNA. This method also relies on the availability
and quality of antibodies. The immunoprecipitated DNA can
be then analyzed by conventional or real-time PCR (ChIP-
PCR) [90]. For genome-wide analyses, ChIP is followed by
microarray hybridization (ChIP-on-chip) [91] or next-genera-
tion sequencing (ChIP-seq) [92]. ChIP-seq has become the
state-of-the-art technology for mapping protein–DNA inter-
actions in a genome-wide fashion, but data analysis is time-
consuming and its application to nonmodel organisms is still
limited.
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surface proteins are encoded by highly polymorphic gene families
(var, rif, stevor, and pfmc-2tm, among others). In the case of the var
family, the ability of the parasite to express only one of the 60
genes that encode for these proteins (called PfEMP1) is epigenet-
ically regulated through histone modifications [22]. In a very
recent study, Rovira-Graells et al. [23] have reported a more
general association between these histone and chromatin marks
and clonally variant expression, extending previous results on
Plasmodium var genes to all but two of the 28 variantly expressed
gene families. In addition, recent work has shown that the
epigenetic state of the parasite is maintained during several rounds
of cell division [24]. Epigenetic control of virulence factors is well
demonstrated in several microbial pathogens. In Entamoeba
histolitica, for example, histone methylation and demethylation
regulate the expression of the amoebapore protein (a protein
responsible for the cytotoxicity of the pathogen [25]). DNA
methylation is also an essential regulatory mechanism of virulence
in several pathogenic bacteria [26,27]. In Salmonella enterica, for
example, lack of Dam (DNA adenine methyltransferase) methyl-
ation causes, amongst other things, envelope instability, reduced
motility, and an impaired ability to invade the intestinal
epithelium [28].
Given the importance of epigenetics for pathogen biology,
understanding how the host environment cues the epigenetic
transition between the replicative and transmission stages and the
virulence factors of morbid and deadly parasites such as Plasmodium
is not only an academic exercise, but it will also provide novel
targets for drug development; an option that has been termed
‘‘epigenetic therapy’’ is currently being tested in clinical trials for other
(noninfectious) diseases. These prevention and treatment strategies
translated to the field of host–parasite interactions could be aimed
at arresting the developmental switches of parasites within the host
or at blocking or limiting their virulence. This could be achieved
by using chemical inhibitors, gene knockout, and RNA interfer-
ence (RNAi) approaches, designed to target the epigenetic
machinery of the parasite such as the DNA methyltransferases
or the chromatin and histone modifying enzymes (see Table 1,
[29]).
Pathogen-Induced Alterations of the Host
Pathogen-induced alterations of host physiology, morphology,
and behavior are widely documented in the scientific literature.
Perhaps the most fascinating examples of these changes are those
that have been shown to be the result of a manipulative strategy of
the pathogen aimed at maximizing its survival and transmission.
Although some of the mechanisms underlying such pathogen
manipulation have been unraveled [30–32], by and large, we
know startlingly little of the strategies used by pathogens to achieve
this end. In the last few years, however, evidence has accumulated
that histone modifications and chromatin remodeling regulate
gene expression and are thus key targets for pathogen manipu-
Figure 2. Comparison between the overall number of science citation-indexed publications in the field of epigenetics (black dots)
and the number of such publications in the field of host–pathogen interactions (grey dots) over the last 30 years (1980 to 2011).
Search carried out on the Web of Science (Thompson Reuters) on June 2012 using a date-restricted search (1980–2011) and ‘‘epigenet*’’ or
‘‘epigenet* and (parasite* or pathogen* or microbe* or bacter* or virus*)’’ as topic search terms.
doi:10.1371/journal.ppat.1003007.g002
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lation during an infection [33]. One such obvious target is the
host’s immune system. In recent years, the epigenetic modulation
of host’s transcriptional program linked to host defense genes has
emerged as a relatively common occurrence of pathogenic viral
and bacterial infections [33,34]. Bacteria are the hallmark of
epigenetic studies on microbes and provide several pioneer
examples on infection-induced host gene reprogramming [32]. A
diverse array of bacterial effectors has been identified that either
mimic or inhibit the host cellular machinery, thus facilitating the
pathogen’s life-cycle. MAPK (mitogen-activated protein kinase),
Interferon (IFN), and transcription factor NF-kB signaling
pathways are common targets of bacterial-induced post-transla-
tional modifications, acetylation, ubiquitylation, and phosphory-
lation on histones and chromatin-associated proteins [35]. Within
the alveolar macrophages, Mycobacterium tuberculosis, for example,
inhibits interferon-c-induced expression of several immune genes
through histone acetylation [36], which explains the persistence of
long-term chronic tuberculosis infections in some patients. This
mechanism is not restricted to bacteria but appears rather
ubiquitous among intracellular pathogens (Table 1). Influenza
viruses go a step further at circumventing host immune defenses.
In a recent study, Marazzi et al. [37] report an influenza protein
called NS1 that contains an amino-acid sequence (ARTK) very
similar to the host’s H3 histone tail. The authors provide
compelling evidence of how using this histone mimic sequence,
the viral NS1 protein hijacks a host transcription elongation factor
(hPAF1), selectively suppressing the cell’s production of antiviral
proteins. This work is a good example of how a molecule of
pathogen origin can directly induce an epigenetic modification in
the host. More studies are needed that establish causative
relationships between the pathogen infection and host epigenetic
modifications such as DNA methylation and posttranslational
histone modifications. Indeed, most of the evidence currently
available is correlational (but see Table 1), and cases where
proteins of pathogen origin have been shown to interact directly
with the host epigenetic machinery are still scarce.
An additional characteristic of many pathogens is their ability to
manipulate the reproductive biology of their hosts. The endo-
bacteria Wolbachia pipientis is the archetypal example of such
reproductive manipulations. Wolbachia is the most common
parasitic microorganism in insects. Its maternal inheritance has
selected for a variety of phenotypes associated with manipulating
the reproduction of its hosts: forcing asexuality, feminizing hosts,
killing males, and inducing incompatibility between infected males
and uninfected (or differently infected) females [38]. Negri et al.
[39] have provided the first evidence that a feminizing strain of
Wolbachia interferes with the genetic imprinting of its host (the
leafhopper Zyginidia pullula) by altering the host’s methylation
pattern. Recently, the widespread existence of putative DNA-
methyltransferases in the prophage of the Wolbachia infecting
several Drosophila species [40] has raised the possibility that this
may be a widespread mechanism of epigenetic interference in this
endosymbiotic bacteria. The link is, however, unclear since these
enzymes have been identified as adenine methyltransferases, a
family of prokaryotic enzymes that methylate the amino group at
the C-6 position of adenines, whereas in the example reported
Figure 3. Schematic representation of the interrelations between epigenetic variation, phenotypic variation, and host–pathogen
interactions. The infection phenotype, which varies between host and pathogen phenotypes and is environmentally dependent, can induce
changes at both the genomic and epigenomic levels. These changes can in turn alter gene expression patterns. Apart from these direct effects of
epigenetic variation on host and pathogen phenotypes, epigenetic variation can also have indirect, and transgenerational, phenotypic effects by
influencing the probability of mutation, transposition, and/or recombination of the DNA sequence, as well as the predisposition of a gene with a
particular epigenetic mark to be selected. See text for further explanation. Red arrows indicate action routes with potential inherited effects (see
Figure 1).
doi:10.1371/journal.ppat.1003007.g003
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above, genetic imprinting of the invertebrate host seems to occur
at the C-5 carbon of CpG cytosines.
Not all modifications that take place in the infected host are,
however, adaptive for the pathogen. Some of them are adaptive
strategies of the host aimed to compensate or minimize the
effects of the infection. In vertebrates, invertebrates, and plants,
individuals that have recovered from certain infectious diseases
are protected against later infection with those same diseases
(immune priming). While the mechanistic basis of immune
priming in invertebrates is still unresolved, in vertebrates,
histone modifications may be associated with immune memory
following a viral infection in CD8 T cells (reviewed in [41]).
Histone modifications, DNA methylation, and other chromatin
remodeling mechanisms, including deposition of histone vari-
ants and ATP-dependent chromatin remodelers, also seem to
serve as a memory for priming in plant immunity [42,43]. In
some cases, acquired immunity can be passed from mother to
offspring, endowing the offspring with improved defense against
infection (transgenerational immune priming). For instance, a
very recent paper has shown that in Arabidopsis thaliana, immune
priming to Pseudomonas syringae is transmitted between plant
generations through the hypomethylation of defense-related
genes [44].
Future Directions
In this review, we have concentrated our attention on the
current evidence available for the role of epigenetic mechanisms in
pathogens’ life cycle and pathogen-induced modification of host
phenotype. However, epigenetics not only represents a paradigm
shift in our understanding of host and pathogen phenotypic
plasticity. We believe that in the next few years, perhaps the most
exciting developments in the field of epigenetics will come by
linking epigenetic variation and inheritance to the epidemiology
and evolution of infectious diseases.
Epigenetic epidemiology has recently emerged as a promising
area for future research on infectious diseases [29,45]. In recent
years, disease association studies based on epigenomic mapping
have arisen as a powerful tool for disease risk prediction in
humans. But these studies typically face the ‘‘chicken-and-egg’’
causality problem: there is an association between a particular
disease phenotype and the epigenome, but it is not easy to establish
whether it is the disease which is causing the epigenetic changes or
whether the epigenetic changes are the ones causing the disease
pathogenesis [29]. New epidemiological approaches are, however,
being developed in epigenetic disease studies to control for such
cause–effect relationships [46]. However, the reversible and
context-dependent nature of epigenetic changes poses serious
caveats to epidemiological studies. For example, many epigenetic
changes linked to disease risk can be lost after one generation,
change from tissue to tissue, or be differentially expressed in an
age-dependent, sex-, and parent-of-origin-specific manner [47–
49]. To overcome these difficulties, epigenetic studies of disease
must be accompanied by comprehensive longitudinal (multistage
and multi-individual) and transgenerational data. Although there
is a lot of effort to bring epigenetics into epidemiological research
in several noninfectious human diseases (see examples reviewed by
[50,51]), we still know very little about the consequences of
epigenetic processes in the emergence and epidemiology of
infectious diseases. Therefore, a comprehensive survey of epige-
netic determinants of pathogenesis coupled with population-level
epigenetic diversity studies in host–pathogen systems is needed
before any disease prediction and prevention strategies can
become a reality [52].
The second area of research is the role of epigenetic variation in
host and pathogen coevolution and evolution. Since the incorporation of
epigenetic inheritance and epigenetic plasticity mechanisms to
evolutionary models and empirical studies of host–pathogen
interactions is still lacking, our discussion is necessarily speculative.
However, we envisage several areas that are ripe for future
research. Models of host–pathogen co-evolution assume the
presence of genetic variation for host resistance and pathogen
infectivity, as well as genotype-specific interactions [53]. Mecha-
nisms of genetic variation alone are, however, often unsatisfactory
to explain the compatibility between host and pathogen pheno-
types [54], and nongenetic inheritance mechanisms may have an
important role to play (e.g., [55–57]). In addition, host–pathogen
co-evolutionary interactions are often context-dependent (i.e.,
spatially and temporally variable), and the output of infection often
depends upon several environmental factors such as temperature
or nutrition [58]. Given the prominent role of epigenetic processes
in environmentally induced phenotypic plasticity and adaptation
[59], the fact that genotype-by-environment interactions in host–
pathogen systems are epigenetically regulated seems a reasonable
assumption. The work by Laine et al. [60] on a fungal pathogen
and its host plant has, for example, demonstrated a temperature-
dependent effect on pathogen performance on local versus foreign
hosts. Multiple cases of environmentally triggered co-adaptations
have been reported in several other host–pathogen systems
(reviewed by [61]), which we contend will provide the raw
material for future epigenetic studies.
A further unresolved matter is to establish the extent, nature,
and significance of epigenetic inheritance in host–pathogen interac-
tions. For example, transgenerational immune priming in inver-
tebrates [62–64] and plants [42] is likely to have an epigenetic
component, but the actual mechanism of inheritance is not known.
Other transgenerational infection effects on host behavior and
physiology, often so-called maternal effects, still need to be
investigated (reviewed by [13]). Several authors (Bonduariansky
and Day [9], Bossdorf et al. [65], Ho and Burggren [66]) have
provided recommendations for testing epigenetic inheritance
experimentally, which could be cross-applied to host–pathogen
studies (Figure S1). In addition, there is an urgent need for
epigenetic studies to develop solid theoretical evolutionary models
[67]. Bonduriansky and Day [9] have suggested that epigenetic
inheritance allows us to overcome three major limitations of
genetic inheritance on phenotypic evolution: (1) It allows for traits
acquired during the lifetime of an individual to be directly
transmitted to the offspring, (2) it allows the transmission of
favorable trait combinations across generations (genetic recombi-
nation tends to break such combinations), and (3) it provides an
additional source of phenotypic variation for selection to act upon.
At present, however, we know startlingly little about how these
phenomena may impact the evolution of host–pathogen interac-
tions. In this sense, the collaboration between molecular
epigeneticists, functional and experimental parasitologists, and
theoretical evolutionary biologists is needed to extend the current
gene-based view of host–pathogen interactions into a more
integrated one that includes both genetic and epigenetic dimen-
sions.
Concluding Remarks
In recent years there has been an explosion in the number of
epigenetics papers across biological disciplines (Figure 2), a
progression that has been accompanied by technological break-
throughs that now make it possible to undertake sophisticated
epigenomic studies across a range of organisms (Box 2 and Table
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S1). However, studies on the complex and multifaceted co-
evolutionary interactions between hosts and pathogens have
received comparatively little attention (Figure 2), and this in spite
of their potentially evolutionary and epidemiological implications.
In this review, we have concentrated our attention on the
current evidence available for those few cases in which an
epigenetic mechanism has been described (i.e., see Table 1), but
we lack evidence on the evolutionary and epidemiological
significance of these changes. Conversely, there are many
pathogen and host traits of key epidemiological importance that
may be epigenetically controlled, some of which may have
transgenerational consequences and whose mechanistic basis
would merit further investigation.
In conclusion, the future is bright for the epigenetics of host–
pathogen interactions. We are confident that in the next few years,
cutting-edge epigenomic techniques combined with experimental
(whole organism), functional, and theoretical (modeling) approach-
es will provide fascinating insights into the interrelations between
genetic, epigenetic, and phenotypic variation in the complex world
of host–pathogen relationships (Figure S2).
Supporting Information
Figure S1 Experimental approach to detect transge-
nerational epigenetic and phenotypic changes of infec-
tion in a model study involving mosquitoes. Starting from
Table 1. Summary table of some of the best characterized epigenetic modifications (DNA methylation and histone
posttranslational modifications [hPTM]) in host–pathogen interactions.
Topic/Organism Epigenetic Mechanism (E): Effectors, (T): Targets Phenotype/Functions Refs
Parasite plasticity
Plasmodium falciparum hPTM (E): protein families ApiAP2,
PfPuf2, PfGCN5, PfSET1, PfSET2,
PfCARM1 & others (T): histones
HP1, H3, H4, H2A, H2B, & others
Sexual & morphological
differentiation (Transmission)
[15] [93] [22,94]
[18] [23,24]
(E): HACs & HMTs (T): H3, Variant
surface antigen families
Virulence (Antigenic variation)
Toxoplasma gondii hPTM & chromatin-
modifying proteins
(E): HDAC, PRMT, MYST, GCN5,
SET, ATP-dependent remodeling
factors, (T): histones H3, H4,
H2A, H2B
Sexual & morphological
differentiation (Transmission)
[18,20]
Entamoeba histolytica hPTM (E): nd, (T): Histones H3, H3K4,
ap-a, cpA5 & lgl1 genes
Virulence (Cytotoxicity) [25]
Salmonella enterica,
Escherichia coli, and others
DNA adenine
methylation
(E): CcrM and DAM, (T):
pathogenicity island I (SPI-1),
lppB gene,
std & spv operon
Virulence (Motility, Cell
adhesion & Invasion, Cytotoxicity)
[28]
Candida albicans DNA methylation (E): nd, (T): RPD3, PBI2,
FOX2 genes
Morphological differentiation
(Transmission)
[21]
Giardia lamblia hPTM (E): HAC & HDAC, (T): nd Morphological differentiation
(Transmission)
[95]
Schistosoma mansoni DNA methylation (E): DNMT2, (T): Smp155010 protein Development (Oviposition) [96]
Epstein-Barr Virus (EBV)
and others
DNA methylation (E): Human cellular DNMTs, (T): Viral
methylome
Virulence [97]
Pathogen-induced host
alterations
Wolbachia pipientis DNA methylation (E): prophage DNMTs?, (T): nd Male feminization [39,40]
Pseudomonas syringae hPTM & DNA
methylation
(E): HAC & HMT, (T): WRKY6 &
WRKY53 genes; DEFENSIN1.2
promoter
Host immune priming [44]
Influenza virus hPTM & DNA
methylation
(E): Viral NS1 (ARSK sequence),
(T): transcription factor PAF1
Host immunosuppression [37]
Human adenovirus (HAdV) hPTM (E): Viral E1A protein (T): IFN
signaling, Histone H2B
Host immunosuppression [98]
Mycobacterium tuberculosis hPTM & chromatin-
modifying proteins
(E): SWI/SNF protein complex
(T): IFN signaling, CIITA promoter
Host immunosuppression [36]
Listeria monocytogenes hPTM & chromatin-
modifying proteins
(E): Listeriolysin O, (T): MAPK
signaling, Histone H4 and H3
Host immunosuppression [33]
Toxoplasma gondii hPTM & chromatin-
modifying proteins
(E): nd, (T): IFN signaling,
transcription factor STAT1
Host immunosuppression [99]
Anaplasma phagocytophilum hPTM & chromatin-
modifying proteins
(E): HDAC1, (T): Histone H3 Host immunosuppression [100]
IFN, Interferon; MAPK, mitogen-activated protein kinase; HAC/HDAC, Histone acetylase/deacetylase; HMTs, Histone methyltransferase; DAM, DNA Adenine
Methyltransferase; DNMT, DNA methyltransferase.
doi:10.1371/journal.ppat.1003007.t001
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isogenic lines and controlled environmental conditions, female
mosquitoes are experimentally infected for successive generations
to detect adaptive traits in response to a continuous selection
pressure (i.e., infection). Phenotype (behavior, immune response,
and physiology), epigenotype, and fitness (i.e., fecundity, longevity,
and survival) are then quantified and statistically compared. In F1,
two groups of females, either infected or noninfected, are back-
crossed with noninfected mosquito control males (NI(C)). If the
descendants of infected (I6NI(C)) versus noninfected lines
(NI(C)6NI) are phenotypically different but show significant
divergence in epigenetic profiles, gene or protein expression—in
spite of being still identical at the DNA level—this will be evidence
for epigenetically based phenotypic change. In subsequent
generations, the comparison of infected versus noninfected
mosquito groups that descend of infected mosquito females will
allow us to test transient versus stable changes (i.e., adaptive traits)
as well as cumulative effects of infection (we may expect them to be
greater in V than in III). In addition, differences between the
descendants of IV–V in Fx will be indicative of maternal effects.
(PDF)
Figure S2 Workflow on research strategies in host–
parasite epigenetics. First, a phenomic (experimental) ap-
proach in laboratory or field settings can be designed to establish
transgenerational phenotypic effects and fitness consequences of
host or pathogen evolutionary-relevant traits for infection. Second,
epigenetic and functional approaches can then be conducted to
examine the mechanistic basis, regulatory pathways, and func-
tional significance of these effects. Third, modeling approaches
can be used to model the long-term consequences of the observed
transgenerational changes, the dynamics and persistence of
different types of epigenetic variation, and the interplay between
epigenetic and genetic variation. Arrows indicate interrelationships
among the different approaches. Feedback among the different
stages (dashed arrows) can serve to generate new hypotheses and
test model predictions.
(PDF)
Table S1 Methodologies for epigenetic analyses.
(DOCX)
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